Literature DB >> 19199688

Investigation of cosolute-protein preferential interaction coefficients: new insight into the mechanism by which arginine inhibits aggregation.

Curtiss P Schneider1, Bernhardt L Trout.   

Abstract

The relatively new technique of vapor pressure osmometry was utilized to determine the preferential interaction of five common solution additives (arginine HCl, guanidine HCl, glycerol, glucose, and urea) using three different model proteins (BSA, lysozyme, and alpha-chymotrypsinogen). Results for guanidine, glycerol, glucose, and urea are comparable to literature values, which utilized the dialysis/densimetry technique. However, values for arginine differ greatly from literature values, making it unclear what is the nature of arginine-protein interactions. A repeat of the dialysis/densimetry measurements reported in the literature supports the vapor pressure osmometry measurements and reveals a never before seen trend in the interaction of arginine with proteins as a function of concentration. This trend is dependent on the protein size and shows arginine to be unique among solution additives. For concentrations below 0.5 M, arginine has a preferential interaction coefficient near zero (slightly greater than zero for small proteins but decreases as the size of the protein increases), which indicates that arginine is neither strongly bound nor excluded from the protein surface. This trend differs greatly from cosolutes that influence the protein folding equilibrium. However, as the concentration of arginine increases beyond 0.5 M, arginine becomes increasingly excluded. Such behavior might be indicative of the protein surface becoming saturated with arginine, thus causing any additional arginine added to the solution to be excluded from interacting with the surface. All of this behavior is most likely the result of a balance between the affinity arginine has for the peptide backbone and certain amino acids and the repulsion generated by surface tension increment and volume exclusion effects [Arakawa et al. Biophysical Chemistry 2007, 127, 1]. In addition, such behavior may explain why arginine has little effect on protein folding equilibrium but is an effective aggregation suppressor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199688      PMCID: PMC2681293          DOI: 10.1021/jp808042w

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  36 in total

1.  Generalized derivation of an exact relationship linking different coefficients that characterize thermodynamic effects of preferential interactions.

Authors:  Charles F Anderson; Daniel J Felitsky; Jiang Hong; M Thomas Record
Journal:  Biophys Chem       Date:  2002-12-10       Impact factor: 2.352

2.  Prevention of thermal inactivation and aggregation of lysozyme by polyamines.

Authors:  Motonori Kudou; Kentaro Shiraki; Shinsuke Fujiwara; Tadayuki Imanaka; Masahiro Takagi
Journal:  Eur J Biochem       Date:  2003-11

3.  Biophysical effect of amino acids on the prevention of protein aggregation.

Authors:  Kentaro Shiraki; Motonori Kudou; Shinsuke Fujiwara; Tadayuki Imanaka; Masahiro Takagi
Journal:  J Biochem       Date:  2002-10       Impact factor: 3.387

4.  Rational design of solution additives for the prevention of protein aggregation.

Authors:  Brian M Baynes; Bernhardt L Trout
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

5.  Physical chemistry of protein solutions; derivation of the equations for the osmotic pressure.

Authors:  G SCATCHARD
Journal:  J Am Chem Soc       Date:  1946-11       Impact factor: 15.419

6.  Preferential interactions of urea with lysozyme and their linkage to protein denaturation.

Authors:  Serge N Timasheff; Guifu Xie
Journal:  Biophys Chem       Date:  2003-09       Impact factor: 2.352

7.  Preferential interactions in aqueous solutions of urea and KCl.

Authors:  Jiang Hong; Michael W Capp; Charles F Anderson; M Thomas Record
Journal:  Biophys Chem       Date:  2003-09       Impact factor: 2.352

8.  The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation.

Authors:  Tsutomu Arakawa; Kouhei Tsumoto
Journal:  Biochem Biophys Res Commun       Date:  2003-04-25       Impact factor: 3.575

9.  Vapor pressure osmometry studies of osmolyte-protein interactions: implications for the action of osmoprotectants in vivo and for the interpretation of "osmotic stress" experiments in vitro.

Authors:  E S Courtenay; M W Capp; C F Anderson; M T Record
Journal:  Biochemistry       Date:  2000-04-18       Impact factor: 3.162

10.  Arginine ethylester prevents thermal inactivation and aggregation of lysozyme.

Authors:  Kentaro Shiraki; Motonori Kudou; Shingo Nishikori; Harue Kitagawa; Tadayuki Imanaka; Masahiro Takagi
Journal:  Eur J Biochem       Date:  2004-08
View more
  18 in total

1.  Predictive tools for stabilization of therapeutic proteins.

Authors:  Vladimir Voynov; Naresh Chennamsetty; Veysel Kayser; Bernhard Helk; Bernhardt L Trout
Journal:  MAbs       Date:  2009-11-10       Impact factor: 5.857

2.  Isotonic concentrations of excipients control the dimerization rate of a therapeutic immunoglobulin G1 antibody during refrigerated storage based on their rank order of native-state interaction.

Authors:  Douglas D Banks; Jon F Cordia; Vladimir Spasojevic; Jeonghoon Sun; Sarah Franc; Younhee Cho
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

3.  Quantitative characterization of local protein solvation to predict solvent effects on protein structure.

Authors:  Vincent Vagenende; Bernhardt L Trout
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

4.  Arginine and the Hofmeister Series: the role of ion-ion interactions in protein aggregation suppression.

Authors:  Curtiss P Schneider; Diwakar Shukla; Bernhardt L Trout
Journal:  J Phys Chem B       Date:  2011-05-13       Impact factor: 2.991

5.  Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.

Authors:  Chaitanya Sudrik; Theresa Cloutier; Phuong Pham; Hardeep S Samra; Bernhardt L Trout
Journal:  MAbs       Date:  2017-07-31       Impact factor: 5.857

6.  Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.

Authors:  Chaitanya M Sudrik; Theresa Cloutier; Neil Mody; Hasige A Sathish; Bernhardt L Trout
Journal:  Pharm Res       Date:  2019-05-24       Impact factor: 4.200

7.  Direct Evidence for the Effect of Glycerol on Protein Hydration and Thermal Structural Transition.

Authors:  Mitsuhiro Hirai; Satoshi Ajito; Masaaki Sugiyama; Hiroki Iwase; Shin-Ichi Takata; Nobutaka Shimizu; Noriyuki Igarashi; Anne Martel; Lionel Porcar
Journal:  Biophys J       Date:  2018-07-17       Impact factor: 4.033

8.  Crowder-Induced Conformational Ensemble Shift in Escherichia coli Prolyl-tRNA Synthetase.

Authors:  Lauren M Adams; Ryan J Andrews; Quin H Hu; Heidi L Schmit; Sanchita Hati; Sudeep Bhattacharyya
Journal:  Biophys J       Date:  2019-08-31       Impact factor: 4.033

9.  Preventing Aggregation of Recombinant Interferon beta-1b in Solution by Additives: Approach to an Albumin-Free Formulation.

Authors:  Najmeh Mahjoubi; Mohammad Reza Fazeli; Rassoul Dinarvand; Mohammad Reza Khoshayand; Ahmad Fazeli; Mohammad Taghavian; Hossein Rastegar
Journal:  Adv Pharm Bull       Date:  2015-11-30

10.  Quantifying the molecular origins of opposite solvent effects on protein-protein interactions.

Authors:  Vincent Vagenende; Alvin X Han; Han B Pek; Bernard L W Loo
Journal:  PLoS Comput Biol       Date:  2013-05-16       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.